跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tobralcin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tobralcin
Approved
STANDARD
Tobralcin
Bharat Biotech International Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4534f41d80e6f392
Company
Bharat Biotech International Ltd.
Type
Standard
Approval Details
Approval Id
4534f41d80e6f392
Drug Approval Philippines Name
Tobralcin
Product Name
Tobralcin
Registration Number
DRP-1577
Brand Name
Tobralcin
Generic Name
Tobramycin Sulfate
Dosage Form
Ophthalmic Solution
Dosage Strength
0.3% w/v
Manufacturer
Bharat Biotech International Ltd.
Importer
SRS Pharmaceuticals Phils., Inc.
Distributor
SRS Pharmaceuticals Phils., Inc.
Company Detail Path
/organization/bharat-biotech-international-ltd
Issuance Date
03 November 2021
Expiry Date
03 August 2027
Pharmacologic Category
Antibiotics
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4534f41d80e6f392
Type
Standard
Back to Philippines FDA Approvals